The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Repeated anti-CEA-radioimmunotherapy (RAIT) with 131iodine-labetuzumab after resection of colorectal liver metastases (CLM): Long-term results of a prospective phase II study.
 
Kia Homayounfar
Honoraria - Merck Serono
Research Funding - Merck Serono (Inst)
 
Carsten O. Sahlmann
No Relationships to Disclose
 
Martin Niessner
No Relationships to Disclose
 
Johannes Meller
No Relationships to Disclose
 
Lena-Christin Conradi
Research Funding - Roche (Inst)
 
Jerzy Dyczkowski
No Relationships to Disclose
 
B. Michael Ghadimi
No Relationships to Disclose
 
Heinz Becker
No Relationships to Disclose
 
David M. Goldenberg
Employment - Immunomedics
Stock and Other Ownership Interests - Immunomedics
Patents, Royalties, Other Intellectual Property - Immunomedics, Inc., Morris Plains, NJ, USA
 
Torsten Liersch
No Relationships to Disclose